UVA Light Device to Treat COVID-19

Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Pilot Study

This pilot study will assess the safety and effectiveness of UV light treatment in hospitalized patients with COVID-19.

This is a single center, open label, pilot study. 5 adult patients, aged over 18, who are confirmed positive with SARS-CoV-2 and are newly intubed, will receive UV light treatment to reduce SARS-CoV-2 viral load.

Inclusion Criteria:

• Confirmed positive test result for SARS-CoV-2
• Mechanically ventilated
• Endotracheal tube inner diameter of at least 7.5 mm

Exclusion Criteria:

• Unable to provide informed consent (or surrogate)
• Enrolled in a therapeutic clinical trial for same condition that does not allow recruitment in other trials
• Pregnant women